DiaMedica Therapeutics Return on Net Operating Assets Insights

DiaMedica Therapeutics, Inc. (DMAC)

7.71 +0.12 (+1.58%) USD | NASDAQ | Mar 06, 16:00

7.72 +0.01 (+0.13%) After-Hours: 20:00

View Return on Net Operating Assets for DMAC.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

XOMA Royalty Corp.	Upgrade
Bristol Myers Squibb Co.	Upgrade
Avantor, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade